TRDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Entrada Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.13 USD -0.56% Market Closed

Market Cap: $276.8m

	Entrada Therapeutics Inc NASDAQ:TRDA	US
	Vela Technologies PLC LSE:VELA	UK
I	Interactive Brokers Group Inc F:KY6	US
E	EUROKAI GmbH & Co KgaA XHAM:EUK2	DE
Y	Yunnan Coal & Energy Co Ltd SSE:600792	CN
S	SEB SA F:GRB	FR
	Lufax Holding Ltd NYSE:LU	CN
	LongDa Construction & Development Corp TWSE:5519	TW
	SEB SA PAR:SK	FR
	Xebec Adsorption Inc TSX:XBC	CA
N	Netflix Inc XHAM:NFC	US
C	Chiang Mai Ram Medical Business PCL SET:CMR	TH

Profitability Summary

Entrada Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-3 767%

Negative 3Y Average Operating Margin

-646%

Declining Operating Margin

-169% > -3 767%

Negative Net Margin

-3 538%

Negative 3Y Average Net Margin

-597%

Declining Net Margin

-190% > -3 538%

Negative Free Cash Flow Margin

-2 867%

Negative 3Y Average Free Cash Flow Margin

-495%

Declining Free Cash Flow Margin

251% > -2 867%

Negative ROE

-54%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

Declining ROIC

-115% > -215%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.